Company news

Hyperfine, Inc. (NASDAQ:HYPR) news

Hyperfine, Inc. news releases on 6ix. Latest, Sep 28, 2026: Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation…

Hyperfine, Inc. (NASDAQ:HYPR) news

Press releases & updates

Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

Hyperfine Announces European Launch of Next-Generation Swoop® System

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Hyperfine Announces Regulatory Approval of the Swoop® System in India

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

Hyperfine Announces Pricing of $17.5 Million Public Offering

Hyperfine Announces Proposed Public Offering

Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Hyperfine Swoop® System Referenced in France’s Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer’s Association International Conference

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software